Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
August-2020 Volume 20 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2020 Volume 20 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

LncRNA MIR4435‑2HG inhibits the progression of osteoarthritis through miR‑510‑3p sponging

  • Authors:
    • Yingli Liu
    • Yun Yang
    • Liangjia Ding
    • Yuqin Jia
    • Yuntao Ji
  • View Affiliations / Copyright

    Affiliations: Rehabilitation Center, The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia 010000, P.R. China, Department of Joint Surgery, The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia 010030, P.R. China, Department of ICU (Intensive Care Unit), The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia 010030, P.R. China, Department of Education office, The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia 010030, P.R. China
    Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1693-1701
    |
    Published online on: June 5, 2020
       https://doi.org/10.3892/etm.2020.8841
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Osteoarthritis (OA) is a disorder of diarthrodial joints that can have multiple causes. Long non‑coding RNAs (lncRNAs) participate in multiple diseases, including OA. It has recently been reported that the lncRNA microRNA 4435‑2HG (MIR4435‑2HG) is downregulated in OA tissues; however, the biological role of MIR4435‑2HG during OA progression remains unclear. In the present study, interleukin (IL)‑1β was used to establish an in vitro model of OA. Protein expressions of matrix metallopeptidase (MMP) 1, MMP13, collagen II, interleukin (IL)‑17A, p65, phosphorylated (p)‑p65, IκB and p‑IκB in CHON‑001 cells were detected by western blotting. Gene expressions of IL‑17A, MIR4435‑2HG and miR‑510‑3p in tissues or CHON‑001 cells were measured by reverse transcription‑quantitative PCR and western blotting, respectively. Cell Counting Kit‑8 assay and immunofluorescence staining were used to investigate cell proliferation, and cell apoptosis was detected by flow cytometry. The association between MIR4435‑2HG, miR‑510‑3p and IL‑17A was investigated using the dual luciferase report assay. MIR4435‑2HG and miR‑510‑3p overexpression were transfected into CHON‑001 cells. The results demonstrated that miR4435‑2HG overexpression significantly increased proliferation and inhibited apoptosis of CHON‑001 cells. In addition, miR‑510‑3p was identified as the downstream target of MIR4435‑2HG, and miR‑510‑3p directly targeted IL‑17A. The results from the present study suggested that MIR4435‑2HG could mediate the progression of OA by inactivating the NF‑κB signaling pathway. In addition, miR4435‑2HG overexpression inhibited OA progression, suggesting that miR4435‑2HG may be considered as a potential therapeutic target in OA.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Thompson RL, Gardner JK, Zhang S and Reinbolt JA: Lower-limb joint reaction forces and moments during modified cycling in healthy controls and individuals with knee osteoarthritis. Clin Biomech (Bristol, Avon). 71:167–175. 2020.PubMed/NCBI View Article : Google Scholar

2 

Brandt KD: Osteoarthritis. Clin Geriatr Med. 4:279–293. 1988.PubMed/NCBI

3 

Mehl J, Imhoff AB and Beitzel K: Osteoarthritis of the shoulder: Pathogenesis, diagnostics and conservative treatment options. Orthopade. 47:368–376. 2018.PubMed/NCBI View Article : Google Scholar : (In German).

4 

Lukusa A, Malemba JJ, Lebughe P, Akilimali P and Mbuyi-Muamba JM: Clinical and radiological features of knee osteoarthritis in patients attending the university hospital of Kinshasa, Democratic Republic of Congo. Pan Afr Med J. 34(29)2019.PubMed/NCBI View Article : Google Scholar

5 

Andreasson I, Kjellby-Wendt G, Fagevik-Olsén M, Aurell Y, Ullman M and Karlsson J: Long-term outcomes of corrective osteotomy for malunited fractures of the distal radius. J Plast Surg Hand Surg. 54:94–100. 2020.PubMed/NCBI View Article : Google Scholar

6 

Nehrer S, Ljuhar R, Steindl P, Simon R, Maurer D, Ljuhar D, Bertalan Z, Dima HP, Goetz C and Paixao T: Automated knee osteoarthritis assessment increases physicians' agreement rate and accuracy: Data from the osteoarthritis initiative. Cartilage: Nov 24, 2019 (Epub ahead of print).

7 

Gerbrands TA, Pisters MF and Vanwanseele B: Individual selection of gait retraining strategies is essential to optimally reduce medial knee load during gait. Clin Biom (Bristol, Avon). 29:828–834. 2014.PubMed/NCBI View Article : Google Scholar

8 

Hochberg-Laufer H, Neufeld N, Brody Y, Nadav-Eliyahu S, Ben-Yishay R and Shav-Tal Y: Availability of splicing factors in the nucleoplasm can regulate the release of mRNA from the gene after transcription. PLoS Genet. 15(e1008459)2019.PubMed/NCBI View Article : Google Scholar

9 

Qi Y, Ma Y, Peng Z, Wang L, Li L, Tang Y, He J and Zheng J: Long noncoding RNA PENG upregulates PDZK1 expression by sponging miR-15b to suppress clear cell renal cell carcinoma cell proliferation. Oncogene: Apr 27, 2020 (Epub ahead of print).

10 

Soares JC, Soares AC, Rodrigues VC, Melendez ME, Santos AC, Faria EF, Reis RM, Carvalho AL and Oliveira ON Jr: Detection of the prostate cancer biomarker PCA3 with electrochemical and impedance-based biosensors. ACS Appl Mater Interfaces. 11:46645–46650. 2019.PubMed/NCBI View Article : Google Scholar

11 

Tu C, Ren X, He J, Zhang C, Chen R, Wang W and Li Z: The Value of LncRNA BCAR4 as a prognostic biomarker on clinical outcomes in human cancers. J Cancer. 10:5992–6002. 2019.PubMed/NCBI View Article : Google Scholar

12 

Jiang Z, Li L, Hou Z, Liu W, Wang H, Zhou T, Li Y and Chen S: LncRNA HAND2-AS1 inhibits 5-fluorouracil resistance by modulating miR-20a/PDCD4 axis in colorectal cancer. Cell Signal. 66(109483)2020.PubMed/NCBI View Article : Google Scholar

13 

Li Y, Li S, Luo Y, Liu Y and Yu N: LncRNA PVT1 regulates chondrocyte apoptosis in osteoarthritis by acting as a sponge for miR-488-3p. DNA Cell Biol. 36:571–580. 2017.PubMed/NCBI View Article : Google Scholar

14 

Xiao Y, Bao Y, Tang L and Wang L: LncRNA MIR4435-2HG is downregulated in osteoarthritis and regulates chondrocyte cell proliferation and apoptosis. J Orthop Surg Res. 14(247)2019.PubMed/NCBI View Article : Google Scholar

15 

Kloppenburg M, Kroon FP, Blanco FJ, Doherty M, Dziedzic KS, Greibrokk E, Haugen IK, Herrero-Beaumont G, Jonsson H, Kjeken I, et al: 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann Rheumatic Dis. 78:16–24. 2019.PubMed/NCBI View Article : Google Scholar

16 

Wang X, Fan J, Ding X, Sun Y, Cui Z and Liu W: Tanshinone I inhibits IL-1β-induced apoptosis, inflammation and extracellular matrix degradation in chondrocytes CHON-001 cells and attenuates murine osteoarthritis. Drug Des Devel Ther. 13:3559–3568. 2019.PubMed/NCBI View Article : Google Scholar

17 

Lin Q and Di YP: Determination and quantification of bacterial virulent gene expression using quantitative real-time PCR. Methods Mol Biol. 2102:177–193. 2020.PubMed/NCBI View Article : Google Scholar

18 

McAlinden A and Im GI: MicroRNAs in orthopaedic research: Disease associations, potential therapeutic applications, and perspectives. J Orthop Res. 36:33–51. 2018.PubMed/NCBI View Article : Google Scholar

19 

Lu F, Liu P, Zhang Q, Wang W and Guo W: Association between the polymorphism of IL-17A and IL-17F gene with knee osteoarthritis risk: A meta-analysis based on case-control studies. J Orthop Surg Res. 14(445)2019.PubMed/NCBI View Article : Google Scholar

20 

Kaul NC, Mohapatra SR, Adam I, Tucher C, Tretter T, Opitz CA, Lorenz HM and Tykocinski LO: Hypoxia decreases the T helper cell-suppressive capacity of synovial fibroblasts by downregulating IDO1-mediated tryptophan metabolism. Rheumatology. 59:1148–1158. 2020.PubMed/NCBI View Article : Google Scholar

21 

Lin S, Zhang R, An X, Li Z, Fang C, Pan B, Chen W, Xu G and Han W: LncRNA HOXA-AS3 confers cisplatin resistance by interacting with HOXA3 in non-small-cell lung carcinoma cells. Oncogenesis. 8(60)2019.PubMed/NCBI View Article : Google Scholar

22 

Nanus DE, Wijesinghe SN, Pearson MJ, Hadjicharalambous MR, Rosser A, Davis ET, Lindsay MA and Jones SW: Obese osteoarthritis patients exhibit an inflammatory synovial fibroblast phenotype, which is regulated by the long non coding RNA MALAT1. Arthritis Rheumatol. 72:1–29. 2019.

23 

Mao T, He C, Wu H, Yang B and Li X: Silencing lncRNA HOTAIR declines synovial inflammation and synoviocyte proliferation and promotes synoviocyte apoptosis in osteoarthritis rats by inhibiting Wnt/β-catenin signaling pathway. Cell Cycle. 18:3189–3205. 2019.PubMed/NCBI View Article : Google Scholar

24 

Tan C, Zhang J, Chen W, Feng F, Yu C, Lu X, Lin R, Li Z, Huang Y, Zheng L, et al: Inflammatory cytokines via up-regulation of aquaporins deteriorated the pathogenesis of early osteoarthritis. PLoS One. 14(e0220846)2019.PubMed/NCBI View Article : Google Scholar

25 

Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP and Fahmi H: Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 7:33–42. 2011.PubMed/NCBI View Article : Google Scholar

26 

Zhang Y, Liu S, Guo W, Hao C, Wang M, Li X, Zhang X, Chen M, Wang Z, Sui X, et al: Coculture of hWJMSCs and pACs in oriented scaffold enhances hyaline cartilage regeneration in vitro. Stem Cells Int. 2019(5130152)2019.PubMed/NCBI View Article : Google Scholar

27 

Wang M, Sampson ER, Jin H, Li J, Ke QH, Im HJ and Chen D: MMP13 is a critical target gene during the progression of osteoarthritis. Arthritis Res Ther. 15(R5)2013.PubMed/NCBI View Article : Google Scholar

28 

Ji B, Ma Y, Wang H, Fang X and Shi P: Activation of the P38/CREB/MMP13 axis is associated with osteoarthritis. Drug Des Devel Ther. 13:2195–2204. 2019.PubMed/NCBI View Article : Google Scholar

29 

Zheng W, Feng Z, Lou Y, Chen C, Zhang C, Tao Z, Li H, Cheng L and Ying X: Silibinin protects against osteoarthritis through inhibiting the inflammatory response and cartilage matrix degradation in vitro and in vivo. Oncotarget. 8:99649–99665. 2017.PubMed/NCBI View Article : Google Scholar

30 

Lorenz J, Seebach E, Hackmayer G, Greth C, Bauer RJ, Kleinschmidt K, Bettenworth D, Böhm M, Grifka J and Grässel S: Melanocortin 1 receptor-signaling deficiency results in an articular cartilage phenotype and accelerates pathogenesis of surgically induced murine osteoarthritis. PLoS One. 9(e105858)2014.PubMed/NCBI View Article : Google Scholar

31 

Lin SL and Ying SY: Mechanism and method for generating tumor-free ips cells using intronic microRNA miR-302 induction. Methods Mol Biol. 1733:265–282. 2018.PubMed/NCBI View Article : Google Scholar

32 

Eguchi T and Kuboki T: Cellular reprogramming using defined factors and microRNAs. Stem Cells Int. 2016(7530942)2016.PubMed/NCBI View Article : Google Scholar

33 

Pourrajab F, Vakili Zarch A, Hekmatimoghaddam S and Zare-Khormizi MR: The master switchers in the aging of cardiovascular system, reverse senescence by microRNA signatures; as highly conserved molecules. Prog Biophys Mol Biol. 119:111–128. 2015.PubMed/NCBI View Article : Google Scholar

34 

Lei J, Fu Y, Zhuang Y, Zhang K and Lu D: LncRNA SNHG1 alleviates IL-1beta-induced osteoarthritis by inhibiting miR-16-5p-mediated p38 MAPK and NF-kappaB signaling pathways. Bioscience reports 39, 2019.

35 

Zhang Y, Wang F, Chen G, He R and Yang L: LncRNA MALAT1 promotes osteoarthritis by modulating miR-150-5p/AKT3 axis. Cell Biosci. 9(54)2019.PubMed/NCBI View Article : Google Scholar

36 

Gao H, Peng L, Li C, Ji Q and Li P: Salidroside alleviates cartilage degeneration through NF-κB pathway in osteoarthritis rats. Drug Des Devel Ther. 14:1445–1454. 2020.PubMed/NCBI View Article : Google Scholar

37 

Xu C, Sheng S, Dou H, Chen J, Zhou K, Lin Y and Yang H: α-Bisabolol suppresses the inflammatory response and ECM catabolism in advanced glycation end products-treated chondrocytes and attenuates murine osteoarthritis. Int Immunopharmacol: Apr 22, 2020 (Epub ahead of print).

38 

Adlakha YK and Saini N: Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128. Mol Cancer. 13(33)2014.PubMed/NCBI View Article : Google Scholar

39 

Plé H, Landry P, Benham A, Coarfa C, Gunaratne PH and Provost P: The repertoire and features of human platelet microRNAs. PLoS One. 7(e50746)2012.PubMed/NCBI View Article : Google Scholar

40 

Wang J, Wang X, Wang L, Sun C, Xie C and Li Z: MiR-let-7d-3p regulates IL-17 expression through targeting AKT1/mTOR signaling in CD4(+) T cells. In vitro Cell Dev Biol Animal. 56:67–74. 2020.PubMed/NCBI View Article : Google Scholar

41 

Zhou X, Chen H, Wei F, Zhao Q, Su Q, Lei Y, Yin M, Tian X, Liu Z, Yu B, et al: α-mangostin attenuates pristane-induced lupus nephritis by regulating Th17 differentiation. Int J Rheum Dis. 23:74–83. 2020.PubMed/NCBI View Article : Google Scholar

42 

Me R, Gao N, Dai C and Yu FX: IL-17 Promotes pseudomonas aeruginosa keratitis in C57BL/6 mouse corneas. J Immunol. 204:169–179. 2020.PubMed/NCBI View Article : Google Scholar

43 

Zhang X, Yuan Y, Pan Z, Ma Y, Wu M, Yang J, Han R, Chen M, Hu X, Liu R, et al: Elevated circulating IL-17 level is associated with inflammatory arthritis and disease activity: A meta-analysis. Clin Chim Acta. 496:76–83. 2019.PubMed/NCBI View Article : Google Scholar

44 

Ghosh S, May MJ and Kopp EB: NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Ann Rev Immunol. 16:225–260. 1998.PubMed/NCBI View Article : Google Scholar

45 

Puri RV, Yerrathota S, Home T, Idowu JY, Chakravarthi VP, Ward CJ, Singhal PC, Vanden Heuvel GB, Fields TA and Sharma M: Notch4 activation aggravates NF-κB mediated inflammation in HIV-1 associated Nephropathy. Dis Mod Mech. 12: pii(dmm040642)2019.PubMed/NCBI View Article : Google Scholar

46 

Baldwin AS Jr: The NF-kappa B and I kappa B proteins: New discoveries and insights. Ann Rev Immunol. 14:649–683. 1996.PubMed/NCBI View Article : Google Scholar

47 

Schütze S, Wiegmann K, Machleidt T and Krönke M: TNF-induced activation of NF-kappa B. Immunobiology. 193:193–203. 1995.PubMed/NCBI View Article : Google Scholar

48 

TH Lv MM, An XM, Leung WK and Seto WK: Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down-regulating the NF-kappaB signaling. J Dig Dis. 21:38–45. 2020.PubMed/NCBI View Article : Google Scholar

49 

Ren H, Wang Z, Zhang S, Ma H, Wang Y, Jia L and Li Y: IL-17A promotes the migration and invasiveness of colorectal cancer cells through NF-κB-mediated MMP expression. Oncol Res. 23:249–256. 2016.PubMed/NCBI View Article : Google Scholar

50 

Sui C, Zhang L and Hu Y: MicroRNA-let-7a inhibition inhibits LPS-induced inflammatory injury of chondrocytes by targeting IL6R. Mol Med Rep. 20:2633–2640. 2019.PubMed/NCBI View Article : Google Scholar

51 

Lu W, Ding Z, Liu F, Shan W, Cheng C, Xu J, He W, Huang W, Ma J and Yin Z: Dopamine delays articular cartilage degradation in osteoarthritis by negative regulation of the NF-kappaB and JAK2/STAT3 signaling pathways. Biomed Pharmacother. 119(109419)2019.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Liu Y, Yang Y, Ding L, Jia Y and Ji Y: LncRNA MIR4435‑2HG inhibits the progression of osteoarthritis through miR‑510‑3p sponging. Exp Ther Med 20: 1693-1701, 2020.
APA
Liu, Y., Yang, Y., Ding, L., Jia, Y., & Ji, Y. (2020). LncRNA MIR4435‑2HG inhibits the progression of osteoarthritis through miR‑510‑3p sponging. Experimental and Therapeutic Medicine, 20, 1693-1701. https://doi.org/10.3892/etm.2020.8841
MLA
Liu, Y., Yang, Y., Ding, L., Jia, Y., Ji, Y."LncRNA MIR4435‑2HG inhibits the progression of osteoarthritis through miR‑510‑3p sponging". Experimental and Therapeutic Medicine 20.2 (2020): 1693-1701.
Chicago
Liu, Y., Yang, Y., Ding, L., Jia, Y., Ji, Y."LncRNA MIR4435‑2HG inhibits the progression of osteoarthritis through miR‑510‑3p sponging". Experimental and Therapeutic Medicine 20, no. 2 (2020): 1693-1701. https://doi.org/10.3892/etm.2020.8841
Copy and paste a formatted citation
x
Spandidos Publications style
Liu Y, Yang Y, Ding L, Jia Y and Ji Y: LncRNA MIR4435‑2HG inhibits the progression of osteoarthritis through miR‑510‑3p sponging. Exp Ther Med 20: 1693-1701, 2020.
APA
Liu, Y., Yang, Y., Ding, L., Jia, Y., & Ji, Y. (2020). LncRNA MIR4435‑2HG inhibits the progression of osteoarthritis through miR‑510‑3p sponging. Experimental and Therapeutic Medicine, 20, 1693-1701. https://doi.org/10.3892/etm.2020.8841
MLA
Liu, Y., Yang, Y., Ding, L., Jia, Y., Ji, Y."LncRNA MIR4435‑2HG inhibits the progression of osteoarthritis through miR‑510‑3p sponging". Experimental and Therapeutic Medicine 20.2 (2020): 1693-1701.
Chicago
Liu, Y., Yang, Y., Ding, L., Jia, Y., Ji, Y."LncRNA MIR4435‑2HG inhibits the progression of osteoarthritis through miR‑510‑3p sponging". Experimental and Therapeutic Medicine 20, no. 2 (2020): 1693-1701. https://doi.org/10.3892/etm.2020.8841
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team